Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

13.38
-0.9400-6.56%
Post-market: 13.380.00000.00%19:30 EDT
Volume:884.65K
Turnover:12.09M
Market Cap:1.14B
PE:-7.67
High:14.30
Open:14.29
Low:13.37
Close:14.32
52wk High:25.77
52wk Low:4.60
Shares:85.31M
Float Shares:54.48M
Volume Ratio:0.72
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7450
EPS(LYR):-0.4650
ROE:-42.66%
ROA:-21.63%
PB:2.34
PE(LYR):-28.78

Loading ...

Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]